Clinical Trial

Study of the Telitacicept in Pediatric Patients With Frequently Relapsing or Steroid Dependent Nephrotic Syndrome

Study acronym: STERN
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The main objective is to evaluate the effectiveness of telitacicept in pediatric patients with frequently relapsing or steroid dependent nephrotic syndrome within the 52-week follow-up.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-11-08.
Trial Details
NCT Number NCT06125405
Lead Sponsor The Children's Hospital of Zhejiang University School of Medicine
Conditions Nephrotic Syndrome in Children, Telitacicept
Enrollment 20 participants
Start Date 2023-11-28
Primary Completion 2026-10-24 (estimated)
Study Completion 2027-10-24 (estimated)
Updated on ClinicalTrials.gov 2024-08-21